The heme synthesis pathway represents a compartmentalized metabolic mechanism in which specific enzymatic reactions occur within distinct cellular locations (mitochondria and cytosol) to produce the iron-porphyrin prosthetic group required for hemoglobin function. This abstract theory delineates the sequence of biochemical conversions from glycine and succinyl-CoA to heme, governed by rate-limiting steps such as ALA synthase activity that are modulated by cofactors like vitamin B6. The domain integrates biochemistry with clinical medicine, establishing a causal framework where enzymatic deficiencies or inhibition lead to specific pathologies characterized by distinct biomarkers of accumulation and cellular toxicity.
The heme synthesis pathway represents a compartmentalized metabolic mechanism in which specific enzymatic reactions occur within distinct cellular locations (mitochondria and cytosol) to produce the …